Generation Bio Debt to Equity Ratio 2020-2023 | GBIO
Current and historical debt to equity ratio values for Generation Bio (GBIO) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Generation Bio debt/equity for the three months ending December 31, 2023 was 0.00.
| Generation Bio Debt/Equity Ratio Historical Data |
| Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
| 2023-12-31 |
$0.17B |
$0.20B |
0.85 |
| 2023-09-30 |
$0.15B |
$0.23B |
0.65 |
| 2023-06-30 |
$0.15B |
$0.25B |
0.59 |
| 2023-03-31 |
$0.15B |
$0.28B |
0.55 |
| 2022-12-31 |
$0.09B |
$0.28B |
0.33 |
| 2022-09-30 |
$0.09B |
$0.31B |
0.31 |
| 2022-06-30 |
$0.09B |
$0.33B |
0.29 |
| 2022-03-31 |
$0.09B |
$0.35B |
0.26 |
| 2021-12-31 |
$0.10B |
$0.38B |
0.25 |
| 2021-09-30 |
$0.06B |
$0.41B |
0.14 |
| 2021-06-30 |
$0.06B |
$0.43B |
0.13 |
| 2021-03-31 |
$0.06B |
$0.46B |
0.12 |
| 2020-12-31 |
$0.03B |
$0.27B |
0.10 |
| 2020-09-30 |
$0.02B |
$0.29B |
0.09 |
| 2020-06-30 |
$0.03B |
$0.30B |
0.09 |
| 2020-03-31 |
$0.00B |
$0.00B |
0.00 |
| 2019-12-31 |
$0.00B |
|
0.00 |
| 2019-09-30 |
$0.00B |
$0.00B |
0.00 |
| 2019-06-30 |
$0.00B |
$0.00B |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.200B |
$0.006B |
|
Generation Bio Co. is a genetic medicines company. It is focused on creating gene therapy for patients suffering from both rare and prevalent diseases. Generation Bio Co. is based in CAMBRIDGE, Mass.
|
